Arcus Biosciences, Inc. — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↑+26.9% +$7M
$33M
R&D↑+19.8% +$20M
$121M
D&A↑+0.0% +$0
$3M
Operating Income↓-35.2% -$37M
$-142M
EBITDA↑+0.0% +$0
$3M
Interest Expense↑+100.0% +$1M
$2M
Other Income/Expense↓-21.4% -$3M
$11M
Pretax Income↓-46.7% -$43M
$-135M
Tax Provision↓-100.0% -$1M
$0
Net Income↓-46.7% -$43M
$-135M
Operating Margin↓-327.4pts
-546.2%
Net Margin↓-327.6pts
-519.2%
Effective Tax Rate↑+0.0pts
0.0%
ETR (Continuing Operations)↑+0.3pts
0.1%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↑+0.2pts
0.1%
Operating Lease Cost↑+0.0% +$0
$13M
Revenue YoY Variation↑+103.7pts
26.9%
Income YoY Variation↓-4.0pts
-35.2%
Revenue QoQ Variation↑+72.8pts
26.9%
Income QoQ Variation↓-1675.9pts
-1675.0%